Andrew Clouston
Overview
Explore the profile of Andrew Clouston including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
1206
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Deacon A, Goetz N, Weber N, Clouston A, Gonsalkorala E, Baskerville C, et al.
J Med Case Rep
. 2023 Jun;
17(1):269.
PMID: 37386640
Background: Hematological malignancies are an infrequent but important cause of liver dysfunction. There are several mechanisms by which this can occur, including direct malignant infiltration of the hepatic parenchyma and/or...
2.
Lemech C, Dredge K, Bampton D, Hammond E, Clouston A, Waterhouse N, et al.
J Immunother Cancer
. 2023 Jan;
11(1).
PMID: 36634920
Background: Pixatimod is a unique activator of the Toll-like Receptor 9 pathway. This phase I trial evaluated safety, efficacy and pharmacodynamics of pixatimod and PD-1 inhibitor nivolumab in immunologically cold...
3.
Young V, Clouston A, Corbett-Burns S, Russell P
Int J Surg Pathol
. 2022 Aug;
31(5):582-584.
PMID: 35971294
No abstract available.
4.
Ooi G, Clouston A, Johari Y, Kemp W, Roberts S, Brown W, et al.
Surg Endosc
. 2020 Mar;
35(3):1210-1218.
PMID: 32170564
Background: Liver biopsy remains the gold standard for characterizing and evaluating treatment response in nonalcoholic fatty liver disease (NAFLD). Liver heterogeneity and sampling variability can affect the reliability of results....
5.
McKay B, Webber L, Manoharan B, Miller G, Clouston A, Bryant R, et al.
ANZ J Surg
. 2020 Jan;
90(6):1099-1103.
PMID: 31983071
Background: Hepatocellular adenoma (HCA) is a hepatocyte derived neoplastic lesion with an increasing incidence and a strong association with oestrogen therapy. Laparoscopic resection has proven safe for small, non-ruptured lesions...
6.
Scott C, Stokes R, Cha K, Clouston A, Eslam M, Metwally M, et al.
PLoS One
. 2019 Dec;
14(12):e0225332.
PMID: 31800592
Background And Aim: Non-alcoholic steatohepatitis (NASH) is predicted to become the most common cause of cirrhosis and liver failure. Risk factors include obesity, insulin resistance and diabetes. Macrophages and other...
7.
Loh Z, Fitzsimmons R, Reid R, Ramnath D, Clouston A, Gupta P, et al.
Br J Pharmacol
. 2019 Jun;
176(19):3775-3790.
PMID: 31236923
Background And Purpose: Chronic liver diseases feature excessive collagen and matrix protein deposition or crosslinking that characterises fibrosis, leads to scar tissue, and disrupts liver functions. There is no effective...
8.
Burt A, Alves V, Bedossa P, Clouston A, Guido M, Hubscher S, et al.
Histopathology
. 2018 Mar;
73(3):369-385.
PMID: 29573451
Optimal patient management benefits from comprehensive and accurate pathology reports that contribute to cancer staging and prognostication. Proforma reports are used in many countries, but these vary in their structure...
9.
Low I, John Harley H, Clouston A
Gastroenterology
. 2018 Feb;
155(2):e7-e8.
PMID: 29408636
No abstract available.
10.
Patel P, Banh X, Horsfall L, Hayward K, Hossain F, Johnson T, et al.
Intern Med J
. 2017 Oct;
48(2):144-151.
PMID: 29083080
Background: Non-alcoholic fatty liver disease (NAFLD) is a common cause of incidental liver test abnormalities. General practitioners (GP) have a key role in identifying people with NAFLD at risk of...